Literature DB >> 21884877

Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.

Imran Sajan1, Cedric Manlhiot, Janette Reyes, Brian W McCrindle, Tilman Humpl, Mark K Friedberg.   

Abstract

BACKGROUND: Pediatric pulmonary arterial hypertension (PAH), whether idiopathic PAH (iPAH) or PAH associated with congenital heart disease (aPAH), carries high morbidity and mortality. Low pulmonary arterial capacitance (PAC), defined as right ventricular stroke volume/pulmonary artery pulse pressure, is a risk factor for mortality in adults with PAH. However, the relation of PAC to pulmonary vascular resistance (PVR), exercise endurance, and survival is poorly defined in children.
METHODS: Catheterization and clinical data of children with PAH (mean pulmonary artery pressure >25 mm Hg) were reviewed. Children with pulmonary shunts, stents, collaterals, or pulmonary venous hypertension were excluded. Primary outcomes were 6-minute walk distance and freedom from death/lung transplant.
RESULTS: Forty-seven patients were studied. Nineteen (43%) had iPAH, and 28 (57%) had aPAH (7.1 ± 6.2 vs 8.4 ± 5.5 years, P = .45). Patients with iPAH had higher PVR indexed for body surface area (PVRi), lower indexed PAC (PACi), lower exercise tolerance, and lower freedom from death/lung transplant than patients with aPAH. Both higher PVRi (P < .0001) and lower PACi (P = .02) were associated with shorter 6-minute walk distance. A PACi <0.70 mL/mm Hg per square meter or >1.25 mL/mm Hg per square meter and a PVRi >13 Wood units × m(2) were associated with decreased freedom from death or lung transplant. The relationships between PVRi and PACi and survival were independent of each other and not confounded by etiologic group.
CONCLUSIONS: Low PACi and high PVRi are independently associated with low 6-minute walk distance and survival in children with PAH. Therefore, both should be assessed for better prognostication and management in this high-risk population.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21884877     DOI: 10.1016/j.ahj.2011.06.014

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension.

Authors:  Richard M Friesen; Michal Schäfer; D Dunbar Ivy; Steven H Abman; Kurt Stenmark; Lorna P Browne; Alex J Barker; Kendall S Hunter; Uyen Truong
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-02-01       Impact factor: 6.875

2.  Cardiac catheterization in children with pulmonary hypertensive vascular disease.

Authors:  Prashant Bobhate; Long Guo; Shreepal Jain; Richard Haugen; James Y Coe; Dominic Cave; Jennifer Rutledge; Ian Adatia
Journal:  Pediatr Cardiol       Date:  2015-01-11       Impact factor: 1.655

Review 3.  Current challenges in pediatric pulmonary hypertension.

Authors:  Shinichi Takatsuki; David Dunbar Ivy
Journal:  Semin Respir Crit Care Med       Date:  2013-09-13       Impact factor: 3.119

4.  Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces.

Authors:  Maria Jesus Del Cerro; Shahin Moledina; Sheila G Haworth; Dunbar Ivy; Maha Al Dabbagh; Hanaa Banjar; Gabriel Diaz; Alexandria Heath-Freudenthal; Ahmed Nasser Galal; Tilman Humpl; Snehal Kulkarni; Antonio Lopes; Ana Olga Mocumbi; G D Puri; Beyra Rossouw; S Harikrishnan; Anita Saxena; Patience Udo; Lina Caicedo; Omar Tamimi; Ian Adatia
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

5.  Noninvasive assessment of pulmonary arterial capacitance by pulmonary annular motion velocity in children with ventricular septal defect.

Authors:  Yasunobu Hayabuchi; Akemi Ono; Yukako Homma; Shoji Kagami
Journal:  Cardiovasc Ultrasound       Date:  2016-09-07       Impact factor: 2.062

6.  Assessment of pulmonary arterial compliance evaluated using harmonic oscillator kinematics.

Authors:  Yasunobu Hayabuchi; Akemi Ono; Yukako Homma; Shoji Kagami
Journal:  Pulm Circ       Date:  2017-06-16       Impact factor: 3.017

7.  Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.

Authors:  Ian Adatia; Sheila G Haworth; Max Wegner; Robyn J Barst; Dunbar Ivy; Kurt R Stenmark; Abraham Karkowsky; Erika Rosenzweig; Christopher Aguilar
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

8.  Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertension.

Authors:  Brandie D Wagner; Shinichi Takatsuki; Frank J Accurso; David Dunbar Ivy
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

9.  Pulmonary Vascular Capacitance as a Predictor of Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension Tested by Adenosine.

Authors:  Davood Shafie; Abolfazl Dohaei; Ahmad Amin; Sepideh Taghavi; Nasim Naderi
Journal:  Res Cardiovasc Med       Date:  2015-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.